Apnimed to Present at the Stifel Healthcare Conference

CAMBRIDGE, Mass. November 8, 2022 – Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies to address obstructive sleep apnea (OSA) and related disorders, including its lead candidate AD109, today announced that management...

Stifel Healthcare Conference

Wednesday, November 16 at 4:10pm to 4:40pm ET LISTEN TO THE WEBCAST or VIEW THE PRESENTATION News 2020 2021 2022 Events Insights Past...